353 related articles for article (PubMed ID: 33047481)
21. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
[TBL] [Abstract][Full Text] [Related]
22. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial.
Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J
Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050
[TBL] [Abstract][Full Text] [Related]
23. Do-it-yourself continuous glucose monitoring in people aged 16 to 69 years with type 1 diabetes: A qualitative study.
Sehgal S; Boucsein A; Styles S; Palmer O; Paul RG; Crocket H; de Bock M; Wheeler BJ
Diabet Med; 2024 Feb; 41(2):e15168. PubMed ID: 37393600
[TBL] [Abstract][Full Text] [Related]
24. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
[TBL] [Abstract][Full Text] [Related]
25. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
[TBL] [Abstract][Full Text] [Related]
26. Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes.
Yamada E; Nakajima Y; Horiguchi K; Okada S; Yamada M
Endocr J; 2023 Dec; 70(12):1187-1193. PubMed ID: 37766568
[TBL] [Abstract][Full Text] [Related]
27. Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study.
Piona C; Marigliano M; Roncarà C; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Passanisi S; Lombardo F; Bonfanti R; Maffeis C
Diabetes Technol Ther; 2023 Jul; 25(7):507-512. PubMed ID: 37155332
[TBL] [Abstract][Full Text] [Related]
28. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
[TBL] [Abstract][Full Text] [Related]
29. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
Battelino T; Alexander CM; Amiel SA; Arreaza-Rubin G; Beck RW; Bergenstal RM; Buckingham BA; Carroll J; Ceriello A; Chow E; Choudhary P; Close K; Danne T; Dutta S; Gabbay R; Garg S; Heverly J; Hirsch IB; Kader T; Kenney J; Kovatchev B; Laffel L; Maahs D; Mathieu C; Mauricio D; Nimri R; Nishimura R; Scharf M; Del Prato S; Renard E; Rosenstock J; Saboo B; Ueki K; Umpierrez GE; Weinzimer SA; Phillip M
Lancet Diabetes Endocrinol; 2023 Jan; 11(1):42-57. PubMed ID: 36493795
[TBL] [Abstract][Full Text] [Related]
30. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review.
Speight J; Choudhary P; Wilmot EG; Hendrieckx C; Forde H; Cheung WY; Crabtree T; Millar B; Traviss-Turner G; Hill A; Ajjan RA
Diabet Med; 2023 Jan; 40(1):e14944. PubMed ID: 36004676
[TBL] [Abstract][Full Text] [Related]
31. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
32. Continuous glucose monitoring systems for type 1 diabetes mellitus.
Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
[TBL] [Abstract][Full Text] [Related]
33. Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study.
Deshmukh H; Adeleke K; Wilmot EG; Folwell A; Barnes D; Walker N; Saunders S; Ssemmondo E; Walton C; Patmore J; Ryder REJ; Sathyapalan T
Diabetes Obes Metab; 2024 Apr; 26(4):1333-1339. PubMed ID: 38164758
[TBL] [Abstract][Full Text] [Related]
34. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
Golden SH; Sapir T
J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
[TBL] [Abstract][Full Text] [Related]
35. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
Choudhary P; Kolassa R; Keuthage W; Kroeger J; Thivolet C; Evans M; Ré R; de Portu S; Vorrink L; Shin J; Habteab A; Castañeda J; da Silva J; Cohen O;
Lancet Diabetes Endocrinol; 2022 Oct; 10(10):720-731. PubMed ID: 36058207
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
[TBL] [Abstract][Full Text] [Related]
37. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
Rotondi MA; Wong O; Riddell M; Perkins B
Diabetes Care; 2022 Sep; 45(9):2012-2019. PubMed ID: 35834175
[TBL] [Abstract][Full Text] [Related]
38. The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes?
Elbalshy M; Boucher S; Galland B; Haszard JJ; Crocket H; Wiltshire E; Jefferies C; de Bock MI; Tomlinson P; Jones S; Wheeler BJ
J Diabetes Metab Disord; 2020 Dec; 19(2):1647-1658. PubMed ID: 33553041
[TBL] [Abstract][Full Text] [Related]
39. To evaluate the use and clinical effect of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: Results of a multicentre study.
Moreno-Fernandez J; Sastre J; Pinés P; Calderon-Vicente D; Gargallo J; Muñoz-Rodriguez JR
Endocrinol Diabetes Nutr (Engl Ed); 2023 Apr; 70(4):270-276. PubMed ID: 37116972
[TBL] [Abstract][Full Text] [Related]
40. Spanish Consensus on the Use of Intermittently Scanned Continuous Glucose Monitoring in the Management of Patients With Insulin Therapy: The MONITOR Project.
Ampudia-Blasco FJ; Ugarte-Abasolo E; Chico A; García-Alemán J; Galan-Barroso M
J Diabetes Sci Technol; 2023 Sep; 17(5):1256-1264. PubMed ID: 35466722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
